Michal Eisenbach-Schwartz

This inventor holds 43 USPTO granted patents and 21 published patent applications, plus 11 CIPO patents and 9 EPO patents, primarily in Neurodegenerative Diseases. Top assignees: Yeda Research and Develpment & Co. Ltd, Immunobrain Checkpoint, Inc., Neuroquest Inc.. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michal Eisenbach-Schwartz. Retrieved from https://idiyas.com/inventor/michal-eisenbach-schwartz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 43 (Patent Applications = 21)

% Patents Active = 72.1

CIPO Patents = 11 (Patent Applications = 5)

EPO Patents = 9 (Patent Applications = 19)

Average Co-Inventor Count = 3.2

ph-index = 12

Forward Citations = 456(Granted Patents)

Company Filing History:

42 out of 1,168

Yeda Research and Develpment & Co. Ltd

patents

2 out of 2

Immunobrain Checkpoint, Inc.

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Alzheimer's Disease

Neurodegenerative Diseases

Regulatory T Cells

CNS Injury

Amyotrophic Lateral Sclerosis

Vaccine Development

Therapeutic Immunization

Mononuclear Phagocytes

Eye Diseases

Neuronal Protection

Neuroprotective Therapy

Kisspeptin Peptides

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12578344 - Compositions, kits, and methods for detecting preclinical alzheimer's disease (2026-03-17),

2. 11884728 - Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis (2024-01-30),

3. 11884727 - Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis (2024-01-30),

4. 11732046 - Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerative disease (2023-08-22),

5. 11643464 - Reducing systemic regulatory T cell levels or activity for treatment of a retinal degeneration disorder (2023-05-09),

6. 11492405 - Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS (2022-11-08),

7. 10995141 - Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerative disease (2021-05-04),

8. 10981989 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2021-04-20),

9. 10961309 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2021-03-30),

10. 10618963 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2020-04-14),

11. 10519237 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2019-12-31),

12. 10214585 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2019-02-26),

13. 10188679 - Human monocyte sub-population for treatment of eye diseases and disorders (2019-01-29),

14. 10144778 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2018-12-04),

15. 9982051 - Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS (2018-05-29),

Title: The Innovative Mind of Michal Eisenbach-Schwartz

Introduction: Michal Eisenbach-Schwartz is a visionary inventor hailing from Rehovot, Israel, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Michal Eisenbach-Schwartz holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, Michal Eisenbach-Schwartz has worked with leading research institutions and tech companies, spearheading projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Michal Eisenbach-Schwartz has collaborated with top scientists, engineers, and entrepreneurs, fostering a culture of innovation and creativity that has led to numerous successful projects and inventions.

Conclusion: Michal Eisenbach-Schwartz continues to push the boundaries of what is possible, inspiring the next generation of inventors and leaving a lasting impact on the world of technology and innovation.

Profile summary based on public USPTO records.